title: Can radiotherapy replace axillary dissection for patients with positive sentinel nodes?
abstract: The substitution of sentinel node biopsy for axillary dissection for patients with early-stage breast cancer has reduced the morbidity of pathologic axillary nodal staging substantially. However, this has resulted in substantial controversy about how to manage patients with positive sentinel nodes. Radiation therapy has been used for many years instead of or in addition to axillary sampling or axillary dissection. This article will examine parts of this experience relevant to the treatment of patients with positive sentinel node biopsy, the limited data on outcome of patients with a positive sentinel node biopsy who do not undergo completion dissection, and the toxicities of axillary irradiation. Finally, I suggest an overall approach to the management of patients with a positive sentinel node biopsy.
authors.affiliation: Department of Radiation Oncology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. arecht@bidmc.harvard.edu
authors.forename: Abram
authors.initials: A
authors.lastname: Recht
mesh_terms: D001365:Axilla; D001943:Breast Neoplasms / Q000473:pathology* / Q000532:radiotherapy* / Q000601:surgery; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology* / Q000601:surgery; D015182:Lymphatic Irradiation; D008207:Lymphatic Metastasis; D021701:Sentinel Lymph Node Biopsy; D016896:Treatment Outcome